<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />

  <title>LiquidMammo™ | Breast cancer screening reimagined</title>

  <!-- SEO -->
  <meta name="description" content="LiquidMammo is a microRNA-based blood test that complements breast cancer screening, helping improve detection performance, especially in dense breasts.">

  <!-- Stylesheet -->
  <link rel="stylesheet" href="assets/css/styles.css" />

  <!-- Favicon -->
  <link rel="icon" href="favicon.png" type="image/png" />
</head>

<body>

<!-- ======================================
     HEADER — LARGE LOGO + BRAND NAME
======================================= -->
<header style="background:white; border-bottom:4px solid #E91E63; padding:18px 0;">
  <div class="container">
    <nav style="display:flex; align-items:center; justify-content:space-between; flex-wrap:wrap; gap:22px;">

      <div class="brand" style="display:flex; align-items:center; gap:18px;">
        <img src="assets/logos/liquidmammo-logo.png" alt="LiquidMammo logo"
             style="height:160px; width:auto;">
        <strong style="font-size:2.35rem; font-weight:900; letter-spacing:-0.8px; color:#E91E63;">
          LiquidMammo™
        </strong>
      </div>

      <!-- ⭐ Pink navigation links -->
      <div class="nav-links"
           style="display:flex; flex-wrap:wrap; gap:22px; font-weight:500; color:#E91E63;">
        <a href="how-it-works.html">How It Works</a>
        <a href="science.html">Science</a>
        <a href="evidence.html">Evidence</a>
        <a href="patients.html">Patients</a>
        <a href="clinicians.html">Clinicians</a>
        <a href="biobank.html">Biobank</a>
        <a href="pricing.html">Pricing</a>
        <a href="contact.html">Contact</a>
        <a href="privacy.html">Privacy</a>
        <a href="about.html">About</a>
      </div>

    </nav>
  </div>
</header>


<!-- ======================================
     HERO
======================================= -->
<section class="hero" style="padding:40px 0; text-align:center;">
  <div class="container">

    <h1 style="font-size:2.4rem; margin-bottom:12px; font-weight:800;">
      Breast cancer screening reimagined
    </h1>

    <p class="small" style="max-width:650px; margin:0 auto 28px auto;">
      A supplemental microRNA-based blood test designed to complement breast imaging by providing
      biologically-driven insight—especially where breast density limits mammographic performance.
    </p>

    <div class="cta-row" style="justify-content:center;">
      <a class="btn" href="patients.html#join">Join Early Access</a>
      <a class="btn secondary" href="clinicians.html#enroll">Clinician Enrollment</a>
    </div>

    <p class="notice" style="max-width:600px; margin:26px auto 0 auto;">
      LiquidMammo is being developed as a
      <strong>CLIA Laboratory Developed Test (LDT)</strong>; not yet FDA‑cleared or FDA‑approved.
    </p>
  </div>
</section>


<!-- ======================================
     WHY IT MATTERS
======================================= -->
<section class="panel-light section">
  <div class="container grid-3">

    <div class="card-mini">
      <h4>Dense breasts challenge mammography</h4>
      <p class="small">
        Sensitivity can fall to ~61% in extremely dense tissue. A molecular complement reduces misses.
      </p>
    </div>

    <div class="card-mini">
      <h4>Earlier biological signal</h4>
      <p class="small">
        microRNA dysregulation can appear before imaging-visible changes.
      </p>
    </div>

    <div class="card-mini">
      <h4>Addresses real-world variability</h4>
      <p class="small">
        Imaging performance varies with density, age, equipment, and technologist. A biological layer improves consistency.
      </p>
    </div>

  </div>
</section>


<!-- ======================================
     CLINICAL CONTEXT
======================================= -->
<section class="section" style="padding:32px 0;">
  <div class="container" style="margin:0 auto; text-align:center;">

    <h2>Clinical context</h2>

    <div class="grid-3" style="justify-items:center; text-align:center;">

      <div class="stats-card">
        <ul class="list-tight">
          <li><strong>Mammograms can miss cancers</strong>, especially in dense breast tissue.</li>
          <li>Interval cancers—those found between screenings—are more common in women with dense breasts.</li>
          <li><strong>False positives are frequent</strong>: many women experience extra imaging or follow‑ups over 10 years.</li>
        </ul>
      </div>

      <div class="stats-card">
        <ul class="list-tight">
          <li>In extremely dense tissue, mammography sensitivity can drop to <strong>~61%</strong>.</li>
          <li>Younger women often have denser breasts, making cancers harder to detect on imaging alone.</li>
          <li>Screening adherence decreases when imaging feels uncertain or stressful.</li>
        </ul>
      </div>

      <div class="card note-card">
        <p class="small">
          LiquidMammo is designed to <strong>support—not replace—imaging</strong> by adding a biological signal that complements
          mammograms. Combining molecular insight with imaging helps strengthen early detection.
        </p>
      </div>

    </div>

  </div>
</section>

<!-- ======================================
     HOW IT WORKS (PREVIEW)
======================================= -->
<section class="panel-light section">
  <div class="container">
    <h2>How it works</h2>

    <div class="grid-3">

      <div class="card-mini">
        <h4>1 — Ordered by clinician</h4>
        <p class="small">Blood draw at routine visit; no preparation required.</p>
      </div>

      <div class="card-mini">
        <h4>2 — microRNA profiling</h4>
        <p class="small">A multi‑marker panel quantifies tumor‑associated biological signals.</p>
      </div>

      <div class="card-mini">
        <h4>3 — Clinician‑ready report</h4>
        <p class="small">Delivered with density‑aware interpretation and subgroup context.</p>
      </div>

    </div>
  </div>
</section>


<!-- ======================================
     FOOTER
======================================= -->
<footer>
  <div class="container footer-grid">

    <div>
      <strong>LiquidMammo™</strong><br/>
      A test developed by MultiOmics Inc.
      <p class="footer-note">
        MultiOmics Inc. is headquartered in Washington, DC, and operates out of LabCentral, Cambridge, MA.
      </p>
    </div>

    <div class="footer-logo">
      <img src="assets/logos/multiomics-logo.png" alt="MultiOmics logo" style="height:22px;">
      <div class="footer-note" style="line-height:1.2">
        Developed by<br/>MultiOmics Inc.
      </div>
    </div>

  </div>

  <div class="container footer-note" style="margin-top:20px;">
    © <script>document.write(new Date().getFullYear())</script> MultiOmics Inc. •
    <a href="privacy.html">Privacy &amp; Compliance</a> •
    <a href="contact.html">Order / Kits</a>
  </div>
</footer>

</body>
</html>

